The Global Knowledge Worker
Special Focus 15-11-2022

Business Risks

Below is a discussion of the most significant risks that could negatively impact the operating results, cash flow and financial position (“operating results, etc.”) of Sumitomo Dainippon Pharma Group. The Group is aware that these risks could occur, works to prevent and minimize them and will take appropriate measures if…

Subscribe Membership Required

You must be a Subscribe member to access this content.

Join Now

Already a member? Log in here

Related posts

Current and prospective value of Artificial Intelligence and Machine Learning in Pharmacovigilance

admin
2 years ago

AI in Pharma Industry

admin
2 years ago

Focus on ESG: Pharma

admin
2 years ago
Exit mobile version